We report that those patients who develop either PTSD or MDD have including 294 genes with hypermethylated cytosine sites and 160 genes with hypomethylated cytosine sites, implicating the function of CREB signaling pathway in neurons which may represent a promising target for therapeutic development and intervention. Here, CREB1 is linked to major depressive disorder.